Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse model is a research paper. On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology βNational Institutes of Health
Grant: 1S10OD020012-01
Mid-Scale RNA Synthesis, Purification and Quality Control System
National Institutes of Health
Grant: 5R01HD086111-03
Development of RNAi based sFLT1-targeting therapeutics for treatment of Preeclampsia
Fields of Study
Keywords